Quercetin-crosslinked porcine heart valve matrix: Mechanical properties, stability, anticalcification and cytocompatibility

Acta Biomaterialia

Volumn 6, Issue 2, 2010, Pages 389-395

  Zhai, Wanyin ^a,b,c   Lü, Xiqin ^d   Chang, Jiang ^a   Zhou, Yanlin ^a   Zhang, Hongfeng ^d  

^a SHANGHAI INSTITUTE OF CERAMICS   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^c SHANGHAI INSTITUTE OF MICROSYSTEM AND INFORMATION TECHNOLOGY   (China)

^d EAST CHINA NORMAL UNIVERSITY   (China)

Author keywords

Crosslinking; Cytocompatibility; ECM; Heart valve; Mechanical property

Indexed keywords

BIOMECHANICS; BIOMINERALIZATION; CELL CULTURE; DURABILITY; ENDOTHELIAL CELLS; FLAVONOIDS; HEART; PHENOLS; SCAFFOLDS (BIOLOGY); TENSILE STRENGTH;

ANTICALCIFICATION; BIOPROSTHETIC HEART VALVES; CROSSLINKED; CYTOCOMPATIBILITY; EXTRACELLULAR MATRICES; GLUTARALDEHYDES; HANKS' SOLUTION; HEART VALVES; IN-VITRO; MATRIX;

CROSSLINKING;

CROSS LINKING REAGENT; GLUTARALDEHYDE; QUERCETIN; TISSUE SCAFFOLD;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BODY FLUID; CALCIFICATION; CELL PROLIFERATION; CLINICAL EFFECTIVENESS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CROSS LINKING; CYTOTOXICITY TEST; DENATURATION; ENDOTHELIUM CELL; ENZYMATIC DEGRADATION; EXTRACELLULAR MATRIX; HEART VALVE; HEART VALVE BIOPROSTHESIS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYDROLYSIS; IN VITRO STUDY; MECHANICAL STRESS; MOLECULAR STABILITY; NONHUMAN; PRIORITY JOURNAL; TEMPERATURE DEPENDENCE; TENSILE STRENGTH; THERMOSTABILITY; TISSUE ENGINEERING; VASCULAR ENDOTHELIUM; YOUNG MODULUS;

SUS;

EID: 72049117373     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2009.07.035     Document Type: Article

References (40)

1. Schmidt C.E., and Baier J.M. Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering. Biomaterials 21 (2000) 2215-2231
2. Schoen F.J., and Levy R.J. Tissue heart valves: current challenges and future research perspectives. J Biomed Mater Res 47 (1999) 439-446
3. Stock U.A., and Schenke-Layland K. Performance of decellularized xenogeneic tissue in heart valve replacement. Biomaterials 27 (2006) 1-2
4. Zhai W., Chang J., Lin K., Wang J., Zhao Q., and Sun X. Crosslinking of decellularized porcine heart valve matrix by procyanidins. Biomaterials 27 (2006) 3684-3690
5. Harborne J.B., and Baxter H. Introduction to volume I{cyrillic, ukrainian}. In: Harborne J.B., and Baxter H. (Eds). The handbook of natural flavonoids (1999), John Wiley, Chichester vii-xiii
6. Sultana B., and Anwar F. Flavonols (kaempeferol, quercetin, myricetin) contents of selected fruits, vegetables and medicinal plants. Food Chem 108 (2008) 879-884
7. Gomathi K., Gopinath D., Ahmed M.R., and Jayakumar R. Quercetin incorporated collagen matrices for dermal wound healing processes in rat. Biomaterials 24 (2003) 2767-2772
8. Tribolo S., Lodi F., Connor C., Suri S., Wilson V.G., Taylor M.A., et al. Comparative effects of quercetin and its predominant human metabolites on adhesion molecule expression in activated human vascular 418 endothelial cells. Atherosclerosis 197 (2008) 50-56
9. Ross J.A., and Kasum C.M. Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr 22 (2002) 19-34
10. Romero M., Jiménez R., Sánchez M., López-Sepúlveda R., Zarzuelo M.J., O'Valle F., et al. Quercetin inhibits vascular superoxide production induced by endothelin-1: role of NADPH oxidase, uncoupled eNOS and PKC. Atherosclerosis 202 (2009) 58-67
11. Machha A., Achike F.I., Mustafa A.M., and Mustafa M.R. Quercetin, a flavonoid antioxidant, modulates endothelium-derived nitric oxide bioavailability in diabetic rat aortas. Nitric Oxide 16 (2007) 442-447
12. Murakami A., Ashida H., and Terao J. Multitargeted cancer prevention by quercetin. Cancer Lett 269 (2008) 315-325
13. Gay C.V., and Lloyd Q.P. Characterization of calcium efflux by osteoblasts derived from long bone periosteum. Comp Biochem Physiol 111A (1995) 257-261
14. Notoya M., Tsukamoto Y., Nishimura H., Woo J.T., Nagai K., Lee I.S., et al. Quercetin, a flavonoid, inhibits the proliferation, differentiation, and mineralization of osteolasts in vitro. Eur J Pharm 485 (2004) 89-96
15. Sung H.W., Chang Y., Chiu C.T., Chen C.N., and Liang H.C. Mechanical properties of a porcine aortic valve fixed with a naturally occurring crosslinking agent. Biomaterials 20 (1999) 1759-1772
16. Miles C.A., Avery N.C., Rodin V.V., and Bailey A.J. The increase in denaturation temperature following cross-linking of collagen is caused by dehydration of the fibres. J Mol Biol 346 (2005) 551-556
17. Sun W.Q., and Leung P. Calorimetric study of extracellular tissue matrix degradation and instability after gamma irradiation. Acta Biomater 4 (2008) 817-826
18. Raghavan D., Simionescu D.T., and Vyavahare N.R. Neomycin prevents enzyme-mediated glycosaminoglycan degradation in bioprosthetic heart valves. Biomaterials 28 (2007) 2861-2868
19. Dowd L.E. Spectrophotometric determination of quercetin. Anal Chem 31 (1950) 1184-1187
20. Yao C., Prevel P., Koch S., Schenck P., Noah E.M., Pallua N., et al. Modification of collagen matrices for enhancing angiogenesis. Cells Tissues Organs 178 (2004) 189-196
21. Sung H.W., Chang Y., Liang I.L., Chang W.H., and Chen Y.C. Fixation of biological tissue with a naturally occurring crosslinking agent: fixation rat and effects of pH, temperature, and initial fixative concentration. J Biomed Mater Res 52 (2000) 77-87
22. Kokubo T., and Takadama H. How useful is SBF in predicting in vivo bone bioactivity?. Biomaterials 27 (2006) 2907-2910
23. Hutchens S.A., Benson R.S., Evans B.R., O'Neill H.M., and Rawn C.J. Biomimetic synthesis of calcium-deficient hydroxyapatite in a natural hydrogel. Biomaterials 27 (2006) 4661-4670
24. Rajamannan N.M., Subramaniam M., Rickard D., Stock S.R., Donovan J., Springett M., et al. Human aortic valve calcification is associated with an osteoblast phenotype. Circulation 107 (2003) 2181-2184
25. Tomazic B.B., Brown W.E., and Schoen F.J. Physicochemical properties of calcific deposits isolated from porcine bioprosthetic heart valves removed from patients following 2-13 years function. J Biomed Mater Res 28 (2004) 35-47
26. Kapolos J., Mavrilas D., Missirlis Y., and Koutsoukos P.G. Model experimental system for investigation of heart valve calcification in vitro. J Biomed Mater Res (Appl Biomater) 38 (1997) 183-190
27. Goo H.C., Hwang Y.S., Yon R.C., Cho H.N., and Suh H. Development of collagenase-resistant collagen and its interaction with adult human dermal fibroblasts. Biomaterials 24 (2003) 5099-6013
28. Stocka U.A., and Schenke-Layland K. Performance of decellularized xenogeneic tissue in heart valve replacement. Biomaterials 27 (2006) 1-2
29. Rao K.P., and Shanthi C. Reduction of calcification by various treatments in cardiac valves. Biomater Appl 13 (1999) 238-268
30. Kokubo T. Design of bioactive bone substitutes based on biomineralization process. Mater Sci Eng C 25 (2005) 97-104
31. Kato R., Nakamura S., Katayama K., and Yamashita K. Electrical polarization of plasma-spray-hydroxyapatite coatings for improvement of osteoconduction of implants. J Biomed Mater Res 74A (2005) 652-658
32. Hartgerink J.D., Beniash E., and Stupp S.I. Self-assembly and mineralization of peptide-amphiphile nanofibers. Science 294 (2001) 1684-1688
33. Bashey R.I., Bashey H.M., and Jimenez S.A. Characterization of pepsin-solubilized bovine heart-valve collagen. Biochem J 173 (1978) 885-894
34. Wine Y., Cohen-Hadar N., Freeman A., and Frolow F. Elucidation of the mechanism and end products of glutaraldehyde crosslinking reaction by X-ray structure analysis. Biotechnol Bioeng 98 (2007) 711-718
35. Han B., Jaurequl J., Tang B.W., and Nimni M.E. Proanthocyanidins: a natural crosslinking reagent for stabilizing collagen matrices. J Biomed Mater Res 65A (2003) 118-124
36. Hagerman A.E., and Butler L.G. The specificity of proanthocyanidin-protein interactions. J Biol Chem 256 (1981) 4494-4497
37. Trantina-Yates A.E., Human P., Bracher M., and Zilla P. Mitigation of bioprosthetic heart valve degeneration through biocompatibility: in vitro versus spontaneous endothelialization. Biomaterials 22 (2001) 1837-1846
38. Dohmen P.M., Costa F., Holinski S., Lopes S.V., Yoshi S., Reichert L.H., et al. Is there a possibility for a glutaraldehyde-free porcine heart valve to grow?. Eur Surg Res 38 (2006) 54-61
39. Booth C., Korossis S.A., Wilcox H.E., Watterson K.G., Kearney J.N., Fisher J., et al. Tissue engineering of cardiac valve prostheses I: development and histological characterization of an acellular porcine scaffold. J Heart Valve Dis 11 (2002) 457-462
40. Leyh R.G., Wilhelmi M., Rebe P., Fischer S., Kofidis T., Haverich A., et al. In vivo repopulation of xenogeneic and allogeneic acellular valve matrix conduits in the pulmonary circulation. Ann Thorac Surg 75 (2003) 1457-1463